The vision “to create a world where we no longer fear cancer” drives the work of Dr. Jaime Modiano and his colleagues in the Animal Cancer Care and Research Program of the University of Minnesota College of Veterinary Medicine. The “Shine On” study represents a turning point in their efforts to achieve this vision, by finding a way to prevent hemangiosarcoma, an aggressive, malignant tumor of blood vessel cells, in dogs.
Latest News
Microphthalmia and Delayed Growth Syndrome
PARKER FORD, PA, February 1, 2017 – The Portuguese Water Dog Foundation is pleased to announce we have signed a Memorandum of Understanding (MOU) along with the Portuguese Water Dog Club of America to collaborate with AKC CHF to jointly fund research at the University of Pennsylvania (UPENN) – Section of Medical Genetics, Pediatrics and Reproduction to better characterize the clinical disorder of syndromic microphthalmia and delayed growth seen in the PWD, commonly known in our breed as Puppy Eye Syndrome (PES). Continue reading “Microphthalmia and Delayed Growth Syndrome”
One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma
Update from the first year of work on MAF co-sponsored project D16CA-056, Measuring chemotherapy drug resistance in dogs with T-cell lymphoma; Paul R. Hess, DVM, PhD, North Carolina State University.
Continue reading “One Year Update Measuring Drug Resistance in Dogs with T-cell Lymphoma”
Year 1 Update for Exploring New Medical Treatments for Cushing’s Syndrome in Dogs
Update for the first year of a 2 year study looking at new medical treatments for dogs with Cushing’s syndrome.
Continue reading “Year 1 Update for Exploring New Medical Treatments for Cushing’s Syndrome in Dogs”
Shine On Progress Update Mid-Year 1
Progress update on Modiano’s research to prevent to hemangiosarcoma. This update provides information on progress mid year 1 of this exciting project.
End-Year 3 Update on Research to Prevent the Spread of Hemangiosarcoma in Dogs
Year-End 3 FINAL update on Modiano’s research to prevent to spread of hemangiosarcoma. Interesting information regarding how this disease adapts to it’s environment in order to spread and ways we can hopefully block it’s spread.
Continue reading “End-Year 3 Update on Research to Prevent the Spread of Hemangiosarcoma in Dogs”
Update Mid-Year 3 – Mapping Genetic Risk Factors for Canine Hip Dysplasia
Update from the middle of year 3 of research underway by Dr. Iivanainen of University of Helsinki to hopefully lead to a genetic test to aid breeders in controlling hip dysplasia.
Continue reading “Update Mid-Year 3 – Mapping Genetic Risk Factors for Canine Hip Dysplasia”
Update Mid Year-3 – Innovations in Prevention, Diagnosis, and Treatment of Cancer
This research update provides information mid-year 3 of a 3-year project looking at prevention, diagnosis, and treatment of cancer in dogs. Principle investigators are Modiano, Breen, and Lindblad-Toh.
Continue reading “Update Mid Year-3 – Innovations in Prevention, Diagnosis, and Treatment of Cancer”
Update End-Year 2 (Final)- Health Implication of Early Spay Neuter
Summary: Final update on findings at the end-year 2 in a study to develop a generalized understanding of the impact of early spay and neuter on disease risk in dogs. The goal of this project was to evaluate, using one consistent and uniform database at their large veterinary medical center (UC Davis). This update provides conclusions for several medium-to-large breed dogs regarding the impact of early spay/neuter on cancer and musculoskeletal risks. Several additional breeds were evaluated since last update. Additionally, several small breeds were evaluated determining negligible risk with early spay/neuter. Findings indicate risk vary from breed to breed.
Continue reading “Update End-Year 2 (Final)- Health Implication of Early Spay Neuter”
Research Update End-Year 2 for Biomarker to Detect Lymphoma Risk, Classify for Treatment and Predict Risk
End-year 2 update of Dr. Jeffery Bryan’s research to discover biomarkers for detection, classification, and treatment of B-cell lymphoma. Progress continues in the researcher’s efforts into this population of B cell lymphomas similar to the aggressive form seen in humans.
